Introduction
Multiple sclerosis (MS) is a debilitating inflammatory central nervous system (CNS) disorder, typically with a relapsing-remitting disease course. Establishment of the diagnosis at the first demyelinating attack, termed clinically isolated syndrome (CIS), remains critical in terms of patient prognosis. 1 Important as it is, the diagnostic process for MS has never been straightforward. 2 Given the difficulty in defining the disease, multiple revisions have been made to its diagnostic criteria. Compared with the 2010 version, 3 characteristics of MS across ethnicities, nations and regions, the 2017 position paper also listed validation in different populations as 1 of its highpriority areas for research. 7 Despite significant improvements, evidence is still lacking on the validity of the 2017 McDonald criteria in China, limiting its application among the Chinese.
Therefore, we set to evaluate the diagnostic performance of the 2017 McDonald criteria. A group of 93 Chinese patients diagnosed with CIS was selected for the evaluation. Our study offered the first evidence for the application of the 2017 McDonald criteria in China, validating its use in Chinese CIS patients.
Methods

Study participants
Individuals with an initial demyelinating attack suspected of MS were recruited between 2012 and 2017 in the Second Affiliated Hospital School of Medicine Zhejiang University, a tertiary hospital in China (Figure 1 ). The inclusion criteria were as follows: (a) age of onset between 11 and 60 years old; (b) an initial clinical attack suggestive of CIS, with both patient-reported symptoms and objective findings; (c) baseline brain magnetic resonance imaging (MRI) (containing gadolinium enhancement) obtained within 3 months of the initial symptom onset; (d) followed up for at least 2 years or diagnosed with clinically definite MS (CDMS); (e) follow-up brain MRI available within 24 months of symptom onset; (f) had no disease-modifying treatment (DMT) before the second clinical episode. Exclusion criteria were as follows: (a) primary progressive subtype of MS (b) aquaporin-4 or myelin oligodendrocyte glycoprotein positivity in the CIS attack or during followup. The definition for CIS, relapses and CDMS were defined previously in the literature. 8, 9 Study design We retrospectively reviewed the medical records and radiological imaging of all enrolled patients. Patients were assessed at baseline and follow-up. At baseline, brain MRI (containing gadolinium enhancement) and routine laboratory tests were performed to rule out alternative diagnosis. At follow-up, brain MRI was ordered when relapses were suspected. We collected information on sex, age of onset, presenting phenotypes [monofocal onset (optic neuritis, myelopathy, brainstem or cerebellar syndrome, hemispheric syndrome), multifocal onset] and OCB results. Clinical outcome was defined as CDMS until the last followup. Patients were divided into CDMS converters and non-converters accordingly.
All patients (n = 93) were included for DIS assessment and survival analysis. Patients with available OCB results at baseline (n = 65) were selected for To evaluate the diagnostic performance, sensitivity, specificity, and accuracy were calculated as previously described. 11 Bias-corrected and accelerated bootstrap method was used to estimate 95% confidence intervals. 12, 13 Comparison of sensitivity and specificity was done with the McNemar test (when b + c < 25, exact McNemar test was used).
Comparison of continuous parametric variables was calculated using a two-tailed t test. Comparison of nonparametric data was calculated using with Mann-Whitney U test. For categorical data, we used χ 2 . To evaluate time to CDMS with different diagnostic criteria, Kaplan-Meier curves were assessed with log-rank tests. Multivariate cox regression was performed to calculate adjusted hazard ratios (HRs) using time to CDMS diagnosis as the outcome, adjusted for age (continuous), sex (binary), the presenting phenotype (categorical), and the availability of OCBs (binary).
Patients who did not meet the criteria for CDMS diagnosis or with a confirmed alternative diagnosis were considered censored observations. P values < 0.05 were considered statistically significant and all p values were two-sided.
Results
Patient characteristics
In total, 93 patients with CIS were recruited. Demographic features of the recruited patients are summarized in Table 1 Table 3 . Figure 2 ). Adjusted HRs are displayed in Table 3 . This present study, to our knowledge, provides the first evidence for the validity of the 2017 McDonald criteria in the Chinese population. A higher sensitivity lowers the hurdle for reaching MS diagnosis and allows an earlier DMT treatment, while specificity is important for correct diagnosis and appropriate management. Previous studies, in line with ours, have reached a consensus on the higher sensitivity of the 2017 criteria (ranging from 66% to 100%). 11, [15] [16] [17] [18] In addition, our study also found the specificity of the 2017 criteria (47.1%) to be significantly lower than the 2010 version, consistent with results from other cohorts (showing a specificity from 13.8% to 85%). 4, 11, [15] [16] [17] This result may imply that adoption of the 2017 criteria, though able to identify more patients at baseline, could culminate in misdiagnosis and overdiagnosis. However, the actual specificity of the 2017 criteria may be higher than estimated. Reasons include the limited follow-up, the use of a strict definition of CDMS as the endpoint, and the lack of advanced MRI protocols for patient evaluation. Among the 9 patients causing the loss in specificity, three were confirmed with an alternative diagnosis. The other 6 remained relapse-free within a median follow-up of 36 months. It is possible that those non-converters had an insidious MRI progression or new cortical lesions that were not detected by our radiological protocol. Given their typical MS-like presentations and OCB positivity at baseline, the 6 non-converters have a high chance to develop a second relapse with a longer follow-up. 19 Taken together, we advocate the use of 2017 McDonald criteria in the Chinese population based on the higher sensitivity, accuracy and its ability to identify more MS patients at an early stage of the disease course.
Contribution of OCBs and symptomatic enhancing lesions
We also examined the contribution of the 2 major revisions in the 2017 McDonald criteria. The inclusion of CSF-OCBs and symptomatic lesions were both associated with a higher sensitivity for MS diagnosis, in parallel with previous studies. 4, 13 Notably, inclusion of CSF-OCBs significantly reduced the specificity. OCB was positive in around half of patients with CIS, similar to other studies on the Chinese population. 20 It was positive in 62.5% of CDMS patients and in 35.3% of non-converters. Among the 5 patients later confirmed with an alternative diagnosis, 60% had OCB positivity at baseline. The data brings to question the specificity of the OCB testing for MS diagnosis. 14 As a matter of fact, the predictive value of OCBs alone for CDMS conversion remains inconclusive. 21, 22 Previous studies, however, have consistently revealed that OCBs, when combined with DIS, were highly predictive of relapses. 15 In addition, incorporating the symptomatic lesions in the DIS criteria numerically lowered the specificity as well, though statistical significance was not reached. We attribute the trend of a lower specificity to the limited followup and the sample size. Other studies also found an increase of false positives after including symptomatic lesions into the criteria. They also found that, with a longer follow-up or the addition of DIT information, specificity improves. 23, 24 Despite the numerical decrease in specificity, the inclusion of symptomatic lesions simplified the diagnostic process and facilitated its implementation. Taken together, both the inclusion of OCBs and symptomatic lesions contributed to the increased sensitivity, while OCBs attributed more to a lower specificity of the 2017 criteria.
Our study has several limitations. First, not all patients underwent a baseline lumbar puncture and spinal cord MRI. This consideration was based on the scope of our study to reflect the real-world scenario for patients diagnosed with CIS. Both of the investigations were not mandatory and the decision was left to the discretion of the treating physician according to the 2017 position paper. 4, 5 Second, given the limited accessibility to advanced MRI techniques, consistent with the real-world setting, the use of 1.5T MRI impeded our ability to detect cortical lesions. The failure to identify cortical lesions as a representation of DIS may contribute to the lower estimated specificity in our study. Future studies with high resolution MRIs with 3.0T would aid in a more accurate evaluation of the 2017 criteria.
Conclusion
This study, based on a real-world setting, offered the first evidence validating the 2017 McDonald criteria among the Chinese population. The 2017 revision had a higher sensitivity, but lower specificity compared with the 2010 iteration, allowing more patients to be diagnosed at an earlier stage in the disease.
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